Navigation Links
Hillary Clinton Returns to Work
Date:1/7/2013

MONDAY, Jan. 7 (HealthDay News) -- Secretary of State Hillary Clinton returned to work Monday, following treatment for a blood clot in her head.

Clinton, 65, was released from a New York hospital Wednesday evening following three days of treatment with blood-thinning medication for the clot. Her doctors said she should make a full recovery. They believe the clot was linked to a concussion she suffered in December.

On Friday, State Department spokeswoman Victoria Nuland described Clinton's condition after her release as "upbeat" and "raring to go," CNN reported.

However, Nuland added that international travel will not be part of Clinton's agenda "for a little while," following doctors' instructions.

The clot was located outside of the brain, in a vein in the space between the brain and the skull behind Clinton's right ear. The general term for the condition is called cerebral venous thrombosis. Clinton's doctors reported that she did not experience any stroke or neurological injury from the clot.

One expert noted that Clinton will need to be careful in the coming weeks.

"The vast majority of venus sinus thrombosis do not have severe symptoms, and are treated with a combination of hydration and anti-coagulants [blood thinners], which cause the [clot] to slowly dissolve," said Dr. Anders Cohen, chief of neurosurgery and spine surgery at The Brooklyn Hospital Center. "It's important that she gets rest and hydration. Because she'll likely be on blood thinners, she'll have to be careful to avoid falls, which could cause significant bleeding.

"The duration of this medication depends on the size of the thrombosis and Mrs. Clinton's clinical status," Cohen added. "Unless she has a hematological condition that predisposes her to [clots], it is unlikely to reoccur. Most likely, the condition was due to her extremely hectic travel schedule. As a result of the travel, she probably suffered from chronic dehydration, which probably led to her fainting episode last month and caused this thrombosis."

Doctors not involved in Clinton's care said blood thinners are typically used to dissolve clots, and patients may need to be on them for weeks or months.

"Therapy is given anywhere from three to six months or longer, depending on other underlying circumstances or cause of the blood clot," said Dr. Jack Ansell, chairman of the department of medicine at Lenox Hill Hospital in New York City. "In Secretary Clinton's case, one would suspect that trauma from her fall played a role. Dehydration, as reported in the news, may also have been a factor. In some patients, there is an underlying hereditary increased tendency to form blood clots, but I am unaware whether this is a factor. Although there is always a risk of recurrence, the risk is very small and most individuals who experience this problem do not have recurrences. A full recovery is expected."

Clinton had been on a strenuous travel schedule in her role as Secretary of State. According to Bloomberg News, the State Department calculates that she has traveled 949,706 miles and visited 112 countries over 401 days -- about 2,084 hours, or nearly 87 days spent airborne.

More information

There's more on blood clots at the U.S. National Library of Medicine.

SOURCES: Anders Cohen, D.O., chief, neurosurgery and spine surgery, The Brooklyn Hospital Center; Jack Ansell, M.D., chairman, department of medicine, Lenox Hill Hospital, New York City; CNN; Bloomberg News


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Hillary Clinton Has Blood Clot in Head, Full Recovery Expected
2. Hillary Clintons Hospital Care for Clot Continues
3. Hillary Clinton Released From NYC Hospital
4. Hillary Clinton Plans to Return to Work Next Week
5. Hillary Clinton to Return to Work
6. Power Slowly Returns to Much of Northeast After Sandy
7. MCG faculty member, former hostage returns to Kuwait as Fulbright Scholar
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hillary Clinton Returns to Work 
(Date:4/21/2017)... ... April 21, 2017 , ... Airway ... new partnership with the highly regarded and well renowned Asian distributor, Discovery Sleep. ... & myTAP PAP Nasal Pillow Mask, and will stabilize and strengthen Airway’s presence ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... imaging practices, is seeking candidates to serve on its Accreditation and Standards ... , “RadSite’s ultimate mission is improving image quality and reducing patient radiation ...
(Date:4/21/2017)... CA (PRWEB) , ... April 21, 2017 , ... ... to experienced, personalized dental care since 1985. After thirty-two years, Dr. Latner has become ... privilege to help my numerous clients over the years with all their dental needs,” ...
(Date:4/21/2017)... ... ... During April 21-23, Super-Sod will join the vendor market of the Sacred Heart ... from the avid gardener to the landscape admirer — during the three-day schedule. , ... grand venue, and we are certainly looking forward to participating in this year’s festival,” ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... ... Service Provider, announces a significant bandwidth upgrade infrastructure service to Tele-Media Solutions. ... Solutions. One of IFN’s consortium member-owners, Tele-Media Solution’s protect transport with 3GB ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: